Genextra S.p.A., 10% Owner at INTERCEPT PHARMACEUTICALS INC (ICPT), bought 390,625 shares at $64.00 ($25.0M) on 2018-04-09, disclosed to the SEC on 2018-04-09.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| Filing → |
| ICPT | SELL | 2018-12-03 | $78.8M | — | Filing → |
| ICPT | SELL | 2014-04-11 | $111.0M | — | Filing → |
| ICPT | SELL | 2013-10-23 | $7.8M | — | Filing → |